{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:21:07Z","timestamp":1793449267871,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2024-00339665"],"award-info":[{"award-number":["RS-2024-00339665"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2022R1C1C2012736 and RS-2023-00266110"],"award-info":[{"award-number":["NRF-2022R1C1C2012736 and RS-2023-00266110"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-23323854"],"award-info":[{"award-number":["RS-2025-23323854"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Alzheimer disease (AD) is a progressive neurodegenerative disorder marked by transcriptomic alterations affecting multiple genes. Many researchers have tried to predict major hallmarks of AD pathogenesis for diagnosis but the association between receptor tyrosine kinase (RTK) pathways and AD diagnosis is still unclear. This study aims to identify RTK-associated gene signatures crucial to AD pathogenesis and assess their potential as diagnostic biomarkers for AD. The study investigated changes in RTK pathway gene expression related to AD by analyzing brain transcriptome data from two independent public data sets (GSE84422 and GSE109887). Differentially expressed genes (DEGs) were analyzed from the GSE84422 and GSE109887 data sets and overlapping genes (oDEGs) were identified. RTK-related genes (ooDEGs) were subsequently selected through functional enrichment analysis. These were further refined into AD-related genes (disease-associated genes (DAGs)) through protein\u2013protein interaction network analysis. Logistic regression and receiver operating characteristic analyses were conducted on the selected DAGs to evaluate their diagnostic potential, with additional gene expression validation performed in brain organoids and primary neurons. A total of 145 genes were identified as oDEGs in the above two data sets, and 18 genes were selected as ooDEGs. Six DAGs (\n                    <jats:italic>ITGB1<\/jats:italic>\n                    ,\n                    <jats:italic>AXL<\/jats:italic>\n                    ,\n                    <jats:italic>GFAP<\/jats:italic>\n                    ,\n                    <jats:italic>NRG1<\/jats:italic>\n                    ,\n                    <jats:italic>CAV1<\/jats:italic>\n                    , and\n                    <jats:italic>RHOA<\/jats:italic>\n                    ) were selected. The diagnostic powers of the six DAGs for AD were 0.825 (GSE84422) and 0.884 (GSE109887). Human brain organoids and primary neuronal models were used to validate the biological relevance of these findings.\n                    <jats:italic>AXL<\/jats:italic>\n                    and\n                    <jats:italic>ITGB1<\/jats:italic>\n                    were finally selected as key genes for RTK pathway in AD and were significantly increased in AD.\n                  <\/jats:p>","DOI":"10.1038\/s12276-026-01684-5","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T07:47:20Z","timestamp":1776239240000},"page":"1230-1241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Human brain and organoid transcriptomes reveal key receptor tyrosine kinase pathways and genetic signatures in Alzheimer's disease"],"prefix":"10.1038","volume":"58","author":[{"given":"Saewoon","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarnai","family":"Amartumur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taehoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Jong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soomin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloofar","family":"Etemadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariunzaya","family":"Jamsranjav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rian","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyusoo","family":"Bak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongjoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Won","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaejeong","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansang","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3446-7288","authenticated-orcid":false,"given":"Sunghoe","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7085-4085","authenticated-orcid":false,"given":"Inhee","family":"Mook-Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7371-8556","authenticated-orcid":false,"given":"Sang-Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Chan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"1684_CR1","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s40120-022-00338-8","volume":"11","author":"AA Tahami Monfared","year":"2022","unstructured":"Tahami Monfared, A. A., Byrnes, M. J., White, L. A. & Zhang, Q. Alzheimer\u2019s disease: epidemiology and clinical progression. Neurol Ther 11, 553\u2013569 (2022).","journal-title":"Neurol Ther"},{"key":"1684_CR2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long, J. M. & Holtzman, D. M. Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179, 312\u2013339 (2019).","journal-title":"Cell"},{"key":"1684_CR3","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom, G. S. Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol 71, 505\u2013508 (2014).","journal-title":"JAMA Neurol"},{"key":"1684_CR4","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3389\/fnins.2019.00659","volume":"13","author":"XQ Chen","year":"2019","unstructured":"Chen, X. Q. & Mobley, W. C. Alzheimer disease pathogenesis: insights from molecular and cellular biology studies of oligomeric A\u03b2 and tau species. Front Neurosci 13, 659 (2019).","journal-title":"Front Neurosci"},{"key":"1684_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/978-94-007-5416-4_14","volume":"65","author":"VJ De-Paula","year":"2012","unstructured":"De-Paula, V. J., Radanovic, M., Diniz, B. S. & Forlenza, O. V. Alzheimer\u2019s disease. Subcell Biochem 65, 329\u2013352 (2012).","journal-title":"Subcell Biochem"},{"key":"1684_CR6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s40478-022-01494-6","volume":"10","author":"S Chen","year":"2022","unstructured":"Chen, S. et al. Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer\u2019s disease. Acta Neuropathol Commun 10, 188 (2022).","journal-title":"Acta Neuropathol Commun"},{"key":"1684_CR7","first-page":"491","volume":"72","author":"PJ Visser","year":"2002","unstructured":"Visser, P. J., Verhey, F. R., Hofman, P. A., Scheltens, P. & Jolles, J. Medial temporal lobe atrophy predicts Alzheimer\u2019s disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry 72, 491\u2013497 (2002).","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1684_CR8","doi-asserted-by":"crossref","unstructured":"Govindpani, K., Turner, C., Waldvogel, H. J., Faull, R. L. M. & Kwakowsky, A. Impaired expression of GABA signaling components in the Alzheimer\u2019s disease middle temporal gyrus. Int. J Mol. Sci. 21, 8704 (2020).","DOI":"10.3390\/ijms21228704"},{"key":"1684_CR9","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1007\/s10571-022-01307-3","volume":"43","author":"IS Piras","year":"2023","unstructured":"Piras, I. S. et al. Integrated DNA methylation\/RNA profiling in middle temporal gyrus of Alzheimer\u2019s disease. Cell Mol Neurobiol 43, 2289\u20132307 (2023).","journal-title":"Cell Mol Neurobiol"},{"key":"1684_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13195-023-01372-w","volume":"16","author":"A Liu","year":"2024","unstructured":"Liu, A., Fernandes, B. S., Citu, C. & Zhao, Z. Unraveling the intercellular communication disruption and key pathways in Alzheimer\u2019s disease: an integrative study of single-nucleus transcriptomes and genetic association. Alzheimers Res. Ther. 16, 3 (2024).","journal-title":"Alzheimers Res. Ther."},{"key":"1684_CR11","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3390\/biom11050660","volume":"11","author":"H Huang","year":"2021","unstructured":"Huang, H. Proteolytic cleavage of receptor tyrosine kinases. Biomolecules 11, 660 (2021).","journal-title":"Biomolecules"},{"key":"1684_CR12","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.brainres.2013.10.049","volume":"1542","author":"AM Pierce","year":"2014","unstructured":"Pierce, A. M. & Keating, A. K. TAM receptor tyrosine kinases: expression, disease and oncogenesis in the central nervous system. Brain Res 1542, 206\u2013220 (2014).","journal-title":"Brain Res"},{"key":"1684_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/cr.2007.5","volume":"17","author":"L Zou","year":"2007","unstructured":"Zou, L. et al. Receptor tyrosine kinases positively regulate BACE activity and amyloid-beta production through enhancing BACE internalization. Cell Res 17, 389\u2013401 (2007).","journal-title":"Cell Res"},{"key":"1684_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0355-3","volume":"8","author":"M Wang","year":"2016","unstructured":"Wang, M. et al. Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer\u2019s disease. Genome Med 8, 104 (2016).","journal-title":"Genome Med"},{"key":"1684_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-019-0755-5","volume":"11","author":"R Lardenoije","year":"2019","unstructured":"Lardenoije, R. et al. Alzheimer\u2019s disease-associated (hydroxy)methylomic changes in the brain and blood. Clin Epigenet 11, 164 (2019).","journal-title":"Clin Epigenet"},{"key":"1684_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-8-392","volume":"8","author":"J Chen","year":"2007","unstructured":"Chen, J., Xu, H., Aronow, B. J. & Jegga, A. G. Improved human disease candidate gene prioritization using mouse phenotype. BMC Bioinform 8, 392 (2007).","journal-title":"BMC Bioinform"},{"key":"1684_CR17","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman, B. T. et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res 50, W216\u2013W221 (2022).","journal-title":"Nucleic Acids Res"},{"key":"1684_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang Da","year":"2009","unstructured":"Huang Da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4, 44\u201357 (2009).","journal-title":"Nat Protoc"},{"key":"1684_CR19","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1093\/bioinformatics\/btx752","volume":"34","author":"A Fabregat","year":"2018","unstructured":"Fabregat, A. et al. Reactome diagram viewer: data structures and strategies to boost performance. Bioinformatics 34, 1208\u20131214 (2018).","journal-title":"Bioinformatics"},{"key":"1684_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20440-5","volume":"12","author":"JC Park","year":"2021","unstructured":"Park, J. C. et al. A logical network-based drug-screening platform for Alzheimer\u2019s disease representing pathological features of human brain organoids. Nat Commun 12, 280 (2021).","journal-title":"Nat Commun"},{"key":"1684_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202201212","volume":"9","author":"JC Park","year":"2022","unstructured":"Park, J. C. et al. Multi-omics-based autophagy-related untypical subtypes in patients with cerebral amyloid pathology. Adv Sci (Weinh) 9, e2201212 (2022).","journal-title":"Adv Sci (Weinh)"},{"key":"1684_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202400064","volume":"11","author":"JC Park","year":"2024","unstructured":"Park, J. C. et al. Microglia gravitate toward amyloid plaques surrounded by externalized phosphatidylserine via TREM2. Adv Sci (Weinh) 11, e2400064 (2024).","journal-title":"Adv Sci (Weinh)"},{"key":"1684_CR23","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1002\/2211-5463.13904","volume":"14","author":"SE Lee","year":"2024","unstructured":"Lee, S. E. et al. Hippocampal tau-induced GRIN3A deficiency in Alzheimer\u2019s disease. FEBS Open Bio 14, 2059\u20132071 (2024).","journal-title":"FEBS Open Bio"},{"key":"1684_CR24","doi-asserted-by":"publisher","first-page":"6749","DOI":"10.1073\/pnas.1600944113","volume":"113","author":"SE Lee","year":"2016","unstructured":"Lee, S. E. et al. nArgBP2 regulates excitatory synapse formation by controlling dendritic spine morphology. Proc Natl Acad Sci USA 113, 6749\u20136754 (2016).","journal-title":"Proc Natl Acad Sci USA"},{"key":"1684_CR25","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.3415","volume":"12","author":"AM Pasca","year":"2015","unstructured":"Pasca, A. M. et al. Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat Methods 12, 671\u2013678 (2015).","journal-title":"Nat Methods"},{"key":"1684_CR26","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1176\/appi.ajp.161.9.1603","volume":"161","author":"T Onitsuka","year":"2004","unstructured":"Onitsuka, T. et al. Middle and inferior temporal gyrus gray matter volume abnormalities in chronic schizophrenia: an MRI study. Am J Psychiatry 161, 1603\u20131611 (2004).","journal-title":"Am J Psychiatry"},{"key":"1684_CR27","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.3892\/mmr.2016.5542","volume":"14","author":"Q Jiang","year":"2016","unstructured":"Jiang, Q. et al. Neuregulin-1 (Nrg1) signaling has a preventive role and is altered in the frontal cortex under the pathological conditions of Alzheimer\u2019s disease. Mol Med Rep 14, 2614\u20132624 (2016).","journal-title":"Mol Med Rep"},{"key":"1684_CR28","first-page":"871","volume":"29","author":"H Ito","year":"2014","unstructured":"Ito, H., Morishita, R., Tabata, H. & Nagata, K. Roles of Rho small GTPases in the tangentially migrating neurons. Histol Histopathol 29, 871\u2013879 (2014).","journal-title":"Histol Histopathol"},{"key":"1684_CR29","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1111\/acel.12521","volume":"15","author":"A Wyssenbach","year":"2016","unstructured":"Wyssenbach, A. et al. Amyloid beta-induced astrogliosis is mediated by beta1-integrin via NADPH oxidase 2 in Alzheimer\u2019s disease. Aging Cell 15, 1140\u20131152 (2016).","journal-title":"Aging Cell"},{"key":"1684_CR30","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169, 1276\u20131290.e17 (2017).","journal-title":"Cell"},{"key":"1684_CR31","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann, S. et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47, 566\u2013581.e9 (2017).","journal-title":"Immunity"},{"key":"1684_CR32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/nature17630","volume":"532","author":"L Fourgeaud","year":"2016","unstructured":"Fourgeaud, L. et al. TAM receptors regulate multiple features of microglial physiology. Nature 532, 240\u2013244 (2016).","journal-title":"Nature"},{"key":"1684_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2006.09.070","volume":"556","author":"BK Son","year":"2007","unstructured":"Son, B. K. et al. Gas6\/Axl-PI3K\/Akt pathway plays a central role in the effect of statins on inorganic phosphate-induced calcification of vascular smooth muscle cells. Eur J Pharmacol 556, 1\u20138 (2007).","journal-title":"Eur J Pharmacol"},{"key":"1684_CR34","doi-asserted-by":"publisher","first-page":"e0152342","DOI":"10.1371\/journal.pone.0152342","volume":"11","author":"N Puthiyedth","year":"2016","unstructured":"Puthiyedth, N., Riveros, C., Berretta, R. & Moscato, P. Identification of differentially expressed genes through integrated study of Alzheimer\u2019s disease affected brain regions. PLoS ONE 11, e0152342 (2016).","journal-title":"PLoS ONE"},{"key":"1684_CR35","doi-asserted-by":"crossref","unstructured":"Zhang, L. et al. Single-cell transcriptomic atlas of Alzheimer\u2019s disease middle temporal gyrus reveals region, cell type and sex specificity of gene expression with novel genetic risk for MERTK in female. medRxiv 2023.02.18.23286037 (2023).","DOI":"10.1101\/2023.02.18.23286037"},{"key":"1684_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/srep31692","volume":"6","author":"J Xu","year":"2016","unstructured":"Xu, J. et al. Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer\u2019s disease model. Sci Rep 6, 31692 (2016).","journal-title":"Sci Rep"},{"key":"1684_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8781","volume":"6","author":"H Tsushima","year":"2015","unstructured":"Tsushima, H. et al. HDAC6 and RhoA are novel players in Abeta-driven disruption of neuronal polarity. Nat Commun 6, 7781 (2015).","journal-title":"Nat Commun"},{"key":"1684_CR38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neulet.2013.02.001","volume":"538","author":"D Min","year":"2013","unstructured":"Min, D. et al. The alterations of Ca2+\/calmodulin\/CaMKII\/CaV1.2 signaling in experimental models of Alzheimer\u2019s disease and vascular dementia. Neurosci Lett 538, 60\u201365 (2013).","journal-title":"Neurosci Lett"},{"key":"1684_CR39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13195-021-00804-9","volume":"13","author":"C Cicognola","year":"2021","unstructured":"Cicognola, C. et al. Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment. Alzheimers Res Ther 13, 68 (2021).","journal-title":"Alzheimers Res Ther"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01684-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01684-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01684-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T02:17:48Z","timestamp":1778033868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01684-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["1684"],"URL":"https:\/\/doi.org\/10.1038\/s12276-026-01684-5","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}